Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea

Hyuk Lee, Sung Noh Hong, Byung Hoon Min, Jun Haeng Lee, Poong Lyul Rhee, Yongchan Lee, Jae J. Kim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Declining of eradication rates for Helicobacter pylori in Korea may be partly from the increasing prevalence of antibiotic resistance, especially clarithromycin resistance. Aim: To compare the efficacy and the safety of using 10-day standard sequential therapy and levofloxacin-containing sequential therapy as a first-line treatment for Helicobacter pylori eradication in Korea. Methods: A total of 200 patients with proven Helicobacter pylori infection randomly received 10-day standard sequential therapy (n= 100) or levofloxacin-containing sequential therapy (n= 100). The standard sequential therapy group received rabeprazole and amoxicillin for 5 days, followed by rabeprazole, clarithromycin, and metronidazole for 5 more days. The levofloxacin-containing sequential therapy group was treated with rabeprazole and amoxicillin for 5 days, followed by rabeprazole, levofloxacin, and metronidazole for 5 more days. Results: Intention-to-treat eradication rates were 79.0% and 78.0% for groups of standard sequential and levofloxacin-containing sequential therapy, respectively (P= 0.863). Per-protocol eradication rates were 84.9% and 81.3%, respectively, for these two therapies (P= 0.498). There were no significant differences between the groups in regard to the eradication rates and adverse events. Conclusions: The 10-day levofloxacin-containing sequential regimen and the standard sequential regimen showed the similar eradication rates of Helicobacter pylori in Korea.

Original languageEnglish
Pages (from-to)114-118
Number of pages5
JournalDigestive and Liver Disease
Volume47
Issue number2
DOIs
Publication statusPublished - 2015 Feb 1

Fingerprint

Levofloxacin
Helicobacter Infections
Korea
Helicobacter pylori
Rabeprazole
Safety
Clarithromycin
Amoxicillin
Metronidazole
Group Psychotherapy
Therapeutics
Microbial Drug Resistance

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Lee, Hyuk ; Hong, Sung Noh ; Min, Byung Hoon ; Lee, Jun Haeng ; Rhee, Poong Lyul ; Lee, Yongchan ; Kim, Jae J. / Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea. In: Digestive and Liver Disease. 2015 ; Vol. 47, No. 2. pp. 114-118.
@article{df368d0e0f9d4f8b83822bd21f30daae,
title = "Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea",
abstract = "Background: Declining of eradication rates for Helicobacter pylori in Korea may be partly from the increasing prevalence of antibiotic resistance, especially clarithromycin resistance. Aim: To compare the efficacy and the safety of using 10-day standard sequential therapy and levofloxacin-containing sequential therapy as a first-line treatment for Helicobacter pylori eradication in Korea. Methods: A total of 200 patients with proven Helicobacter pylori infection randomly received 10-day standard sequential therapy (n= 100) or levofloxacin-containing sequential therapy (n= 100). The standard sequential therapy group received rabeprazole and amoxicillin for 5 days, followed by rabeprazole, clarithromycin, and metronidazole for 5 more days. The levofloxacin-containing sequential therapy group was treated with rabeprazole and amoxicillin for 5 days, followed by rabeprazole, levofloxacin, and metronidazole for 5 more days. Results: Intention-to-treat eradication rates were 79.0{\%} and 78.0{\%} for groups of standard sequential and levofloxacin-containing sequential therapy, respectively (P= 0.863). Per-protocol eradication rates were 84.9{\%} and 81.3{\%}, respectively, for these two therapies (P= 0.498). There were no significant differences between the groups in regard to the eradication rates and adverse events. Conclusions: The 10-day levofloxacin-containing sequential regimen and the standard sequential regimen showed the similar eradication rates of Helicobacter pylori in Korea.",
author = "Hyuk Lee and Hong, {Sung Noh} and Min, {Byung Hoon} and Lee, {Jun Haeng} and Rhee, {Poong Lyul} and Yongchan Lee and Kim, {Jae J.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.dld.2014.10.014",
language = "English",
volume = "47",
pages = "114--118",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier",
number = "2",

}

Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea. / Lee, Hyuk; Hong, Sung Noh; Min, Byung Hoon; Lee, Jun Haeng; Rhee, Poong Lyul; Lee, Yongchan; Kim, Jae J.

In: Digestive and Liver Disease, Vol. 47, No. 2, 01.02.2015, p. 114-118.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea

AU - Lee, Hyuk

AU - Hong, Sung Noh

AU - Min, Byung Hoon

AU - Lee, Jun Haeng

AU - Rhee, Poong Lyul

AU - Lee, Yongchan

AU - Kim, Jae J.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Background: Declining of eradication rates for Helicobacter pylori in Korea may be partly from the increasing prevalence of antibiotic resistance, especially clarithromycin resistance. Aim: To compare the efficacy and the safety of using 10-day standard sequential therapy and levofloxacin-containing sequential therapy as a first-line treatment for Helicobacter pylori eradication in Korea. Methods: A total of 200 patients with proven Helicobacter pylori infection randomly received 10-day standard sequential therapy (n= 100) or levofloxacin-containing sequential therapy (n= 100). The standard sequential therapy group received rabeprazole and amoxicillin for 5 days, followed by rabeprazole, clarithromycin, and metronidazole for 5 more days. The levofloxacin-containing sequential therapy group was treated with rabeprazole and amoxicillin for 5 days, followed by rabeprazole, levofloxacin, and metronidazole for 5 more days. Results: Intention-to-treat eradication rates were 79.0% and 78.0% for groups of standard sequential and levofloxacin-containing sequential therapy, respectively (P= 0.863). Per-protocol eradication rates were 84.9% and 81.3%, respectively, for these two therapies (P= 0.498). There were no significant differences between the groups in regard to the eradication rates and adverse events. Conclusions: The 10-day levofloxacin-containing sequential regimen and the standard sequential regimen showed the similar eradication rates of Helicobacter pylori in Korea.

AB - Background: Declining of eradication rates for Helicobacter pylori in Korea may be partly from the increasing prevalence of antibiotic resistance, especially clarithromycin resistance. Aim: To compare the efficacy and the safety of using 10-day standard sequential therapy and levofloxacin-containing sequential therapy as a first-line treatment for Helicobacter pylori eradication in Korea. Methods: A total of 200 patients with proven Helicobacter pylori infection randomly received 10-day standard sequential therapy (n= 100) or levofloxacin-containing sequential therapy (n= 100). The standard sequential therapy group received rabeprazole and amoxicillin for 5 days, followed by rabeprazole, clarithromycin, and metronidazole for 5 more days. The levofloxacin-containing sequential therapy group was treated with rabeprazole and amoxicillin for 5 days, followed by rabeprazole, levofloxacin, and metronidazole for 5 more days. Results: Intention-to-treat eradication rates were 79.0% and 78.0% for groups of standard sequential and levofloxacin-containing sequential therapy, respectively (P= 0.863). Per-protocol eradication rates were 84.9% and 81.3%, respectively, for these two therapies (P= 0.498). There were no significant differences between the groups in regard to the eradication rates and adverse events. Conclusions: The 10-day levofloxacin-containing sequential regimen and the standard sequential regimen showed the similar eradication rates of Helicobacter pylori in Korea.

UR - http://www.scopus.com/inward/record.url?scp=84921304092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921304092&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2014.10.014

DO - 10.1016/j.dld.2014.10.014

M3 - Article

VL - 47

SP - 114

EP - 118

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 2

ER -